Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Antibe Therapeutics Inc(Pre-Merger) ATBPF

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug,... see more

GREY:ATBPF - Post Discussion

View:
Post by Doccole on Nov 03, 2021 2:06pm

Catalyst

What catalysts will help this stock grow? Insider buys bumped it, now back to stagnant.  Thoughts?
Comment by MrMugsy on Nov 03, 2021 3:03pm
If you are looking for potential items that could move the stock ... here are a few things to think about ... 1. 346 (acute) fast-track application and then a further acceptance from FDA 60 days later (assuming we get it) 2. 352 details to emerge - large unmet need in acute ???  Also any fast-track to go with that ??? 3. chronic regimen update and further timelines on development 4. IBD ...more  
Comment by Doccole on Nov 03, 2021 5:17pm
I don't know mugs, lots of those potential catalysts seem far away. In you opinion, when would the fast track application be applied for?
Comment by MrMugsy on Nov 03, 2021 6:24pm
From what I've read, you can apply anytime. Not sure if it only applies to the review of the data after Phase 3 or if it gives you some priority at other points as well.  Maybe someone can answer that. I think 1, 2, 4 and 5 can happen at any time - IMO. The others are likely out 6 plus months. These are just armchair guess as per your question though.
Comment by Doccole on Nov 03, 2021 8:37pm
You are right, thanks for the thoughts.   I am hoping for excitement here.  Hopefully the crew will wow us with something.  It would be nice to get the mc moving.  
Comment by Daydream2 on Nov 04, 2021 7:52am
There's plenty of insider buy in right now, there's a catalyst.
Comment by MrMugsy on Nov 04, 2021 11:49am
Well said Daydream. It can be a catalyst. Hoping it doesn't just peter out as buying comes to an end. I think we need some material things to drive analyst's projections. The insider buying may help colour analyst's opinions ... but ... something material is what will change sentiment. IMO
Comment by Jefnan1 on Nov 04, 2021 1:51pm
The total insider buying amounts to less than $200k. It is nothing to get excited about. If the board would allow the company to buy back $1 million worth of  shares would be a big indication that they believe there is value 
Comment by Inthepez on Nov 04, 2021 2:24pm
This post has been removed in accordance with Community Policy
Comment by Jefnan1 on Nov 04, 2021 3:05pm
This post has been removed in accordance with Community Policy
Comment by StockingUp21 on Nov 04, 2021 3:21pm
This post has been removed in accordance with Community Policy
Comment by Inthepez on Nov 04, 2021 3:27pm
This post has been removed in accordance with Community Policy
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities